Global Embolic Protection Devices Market To Record Lucrative Growth With US$ 1,400.8 Million USD By 2027

March 2022 | Report Format: Electronic (PDF)

Embolic protection devices (EPDs) are the most common type of device used during percutaneous cardiac procedures. The use of embolic protection devices (EPD) during percutaneous cardiac procedures has helped to reduce the number of complications caused by debris entering the bloodstream and clogging smaller vessels. These devices are a component of the most effective, scientifically proven treatment for preventing periprocedural myocardial infarction and other major cardiovascular events. Depending on their mechanism of action, EPDs are classified as distal occlusion aspiration devices, distal filters, or proximal occlusion aspiration devices.

Request a Free Sample Copy: Embolic Protection Devices Market Report

Embolic Protection Devices Market Report Highlights

• In October 2021, Keystone Heart Ltd., a Venus Medtech company, revealed that the TriGUARD 3 Cerebral Embolic Protection (CEP) Device had earned European CE label.
• In April 2017, Contego Medical, LLC, one of the major players, reported that its latest product Vanguard IEPa had earned CE Mark.

EMBOLIC PROTECTION DEVICES MARKET SEGMENTATION

The research report published by Market Research Strategy contains industry segments, as below-

Embolic Protection Devices Product Outlook (Revenue, USD Million, 2016 - 2027)

• Distal Filter Devices
• Distal Occlusion Devices
• Proximal Occlusion Devices

Embolic Protection Devices Application Outlook (Revenue, USD Million, 2016 - 2027)

• Coronary Artery Treatment
• Carotid Artery Treatment   
• Others

Embolic Protection Devices Procedure Outlook (Revenue, USD Million, 2016 - 2027)

• Percutaneous Coronary Intervention
• Carotid Artery Stenosis
• Saphenous Vein Graft Intervention
• Aortic Valve Stenosis
• Others

Embolic Protection Devices Material Outlook (Revenue, USD Million, 2016 - 2027)

• Nitinol
• Polyurethane

Embolic Protection Devices Usage Outlook (Revenue, USD Million, 2016 - 2027)

• Disposable Devices
• Re-Usable Devices

Embolic Protection Devices End User Outlook (Revenue, USD Million, 2016 - 2027)

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others

Embolic Protection Devices Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa

List of Key Players- Embolic Protection Devices Market

• Abbott Laboratories
• Allium Medical Solutions Ltd.
• Boston Scientific Corporation
• Cardinal Health Inc.
• Contego Medical LLC
• Innovative Cardiovascular Solutions LLC
• Edwards Lifesciences Corporation
• Medtronic Inc.
• Silk Road Medical Inc.

About Market Research Strategy:

Market Research Strategy (MRS) is a dedicated and disciplined market research firm that delivers authentic consulting services with accurate data forecasting for research-related services. The positive and result-oriented approaches implemented by us are beneficial in identifying the market challenges of any brand or start-up company to penetrate the competitive business space.

MRS also supports numerous organizations with its syndicate data and research reports to establish and survive in the market by grabbing the available market opportunities. Our vast experience and huge client database turn out to be our wealth and also secures our market position at the top of the list. Besides, we make use of every single piece of information, mined from authentic sources, into a valuable asset of the report; aiding our clients with informed business decisions.

Contact Us:

Market Research Strategy

473 Mundet Place,

Ste US520501 Hillside

New Jersey 07205 United States

USA Phone: ++1 9176726599

Business Email: sales@marketresearchstrategy.com

Website: https://marketresearchstrategy.com/